ResearcherMayo ClinicNo recent work listed

Lori A. Erickson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3666-2546; OpenAlex author ID A5010735971. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper

Papers 2

Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.mayocp.2017.07.002 ↗
Targeting the hypoxia pathway to treat pancreatic cancer. First author DOI 10.2147/dddt.s80888 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Peiwen Fei · 1 shared paper, 2015 · strength 0.07
- Paper Targeting the hypoxia pathway to treat pancreatic cancer. DOI 10.2147/dddt.s80888 ↗
Jun Zhang · 1 shared paper, 2015 · strength 0.07
- Paper Targeting the hypoxia pathway to treat pancreatic cancer. DOI 10.2147/dddt.s80888 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.